The increasing prevalence of diabetes in pets, along with the growing awareness about pet healthcare, is expected to drive the demand for diabetes care devices in the market. Furthermore, the rising adoption of pets, especially in developed countries, is also fueling the growth of the pet diabetes care devices market. Additionally, technological advancements in glucose monitoring devices and insulin delivery systems are expected to provide significant growth opportunities for the market.
Industry
Report Coverage | Details |
---|---|
Segments Covered | Device, Animal, End-use |
Regions Covered | • North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | Merck animal health, Becton, Fitbark, TaiDoc, Dickinson, Allison Medical, Henry Schein, Zoetis, Ulticare, Boehringer Ingelheim Vetmedica, IDEXX Laboratories, Johnson & Johnson Services, Inc, Novo Nordisk, Eli Lilly and Company, Vetoquinol S.A. |
The high cost associated with pet diabetes care devices is likely to restrain market growth, particularly in developing regions where the affordability of such devices is a concern. Moreover, the lack of awareness about diabetes in pets among pet owners and veterinary professionals could also hinder market growth by limiting the adoption of diabetes care devices for pets.